Macular Edema

Showing 91 to 91 of 91 articles

Clear Filters

Anatomical and visual outcome of intravitreal bevacizumab (Avastin) in patients with diabetic macular edema.

Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH Jan 1, 2016

BACKGROUND: Intravitreal bevacizumab has been shown to be an effective treatment of diabetic macular edema.

Humans Diabetic Retinopathy Angiogenesis Inhibitors Treatment Outcome Visual Acuity Corneal Topography Tomography, Optical Coherence Macular Edema Intravitreal Injections Recurrence Fluorescein Angiography Bevacizumab

View on PubMed DOI

Recent Journals

Scientific reports 4956
Sensors (Basel, Switzerland) 4710
PloS one 3700
Neural networks : the official journal of the International Neural Network Society 2841
Computational intelligence and neuroscience 1931
Computers in biology and medicine 1688
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 1686
Studies in health technology and informatics 1141
IEEE journal of biomedical and health informatics 1040
Journal of chemical information and modeling 911
Nature communications 839
Bioinformatics (Oxford, England) 837
Computer methods and programs in biomedicine 835
Briefings in bioinformatics 833
IEEE transactions on neural networks and learning systems 772

AI Medical Compendium Topic

Explore the latest research on artificial intelligence and machine learning in medicine.

Macular Edema

Anatomical and visual outcome of intravitreal bevacizumab (Avastin) in patients with diabetic macular edema.

Popular Topics

Recent Journals